The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Breslow Michael J since 2006.
The trader's CIK number is 1352906.
At the time of the last reporting, Breslow Michael J was the EVP Clinical R&D of Visicu Inc. (stock ticker symbol EICU).
Also see all insider trading activities at Visicu Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | EICU | 0 | $0 | 75,508 | $708,356 | 0 | $0 |
| 2006 | EICU | 0 | $0 | 20,000 | $196,705 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-10-05 | EICU | Sale | 100 | 8.00 | 800 |
| 2007-09-21 | EICU | Sale | 5,000 | 8.00 | 40,000 |
| 2007-08-06 | EICU | Sale | 978 | 8.00 | 7,824 |
| 2007-08-07 | EICU | Sale | 4,022 | 8.00 | 32,176 |
| 2007-07-02 | EICU | Sale | 5,000 | 9.13 | 45,660 |
| 2007-06-08 | EICU | Sale | 3,250 | 10.00 | 32,500 |
| 2007-06-01 | EICU | Sale | 8,450 | 9.79 | 82,750 |
| 2007-05-30 | EICU | Sale | 2,600 | 10.00 | 26,000 |
| 2007-05-31 | EICU | Sale | 5,700 | 10.00 | 57,000 |
| 2007-05-01 | EICU | Sale | 5,000 | 8.63 | 43,150 |
| 2007-04-30 | EICU | Sale | 5,000 | 10.06 | 50,300 |
| 2007-04-20 | EICU | Sale | 9,592 | 8.00 | 76,736 |
| 2007-03-23 | EICU | Sale | 408 | 8.00 | 3,264 |
| 2007-03-23 | EICU | Sale | 408 | 8.00 | 3,264 |
| 2007-02-01 | EICU | Sale | 10,000 | 10.34 | 103,400 |
| 2007-01-03 | EICU | Sale | 5,300 | 10.15 | 53,821 |
| 2007-01-03 | EICU | Sale | 2,700 | 10.32 | 27,869 |
| 2007-01-03 | EICU | Sale | 2,000 | 10.92 | 21,842 |
| 2006-12-01 | EICU | Sale | 10,000 | 10.00 | 100,000 |
| 2006-11-07 | EICU | Sale | 5,000 | 10.00 | 50,000 |
| 2006-11-03 | EICU | Sale | 5,000 | 9.34 | 46,705 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Breslow Michael J (EVP Clinical R&D of Visicu Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.